Resources

Selected
  • 国电电力 2025年光伏毛利率
Type of publications
Regions
Diseases
273 results found
2024 ∙ NACI
Recommendations on the use of pneumococcal vaccines in adults, including PNEU-C-21
Recommendation Americas Canada Adults Pneumococcal disease
Download:
2024 ∙ JCVI
Flu vaccines 2025 to 2026: JCVI advice
Recommendation Europe United Kingdom Influenza
Download:
2024 ∙ JCVI
COVID-19 vaccination in 2025 and spring 2026: JCVI advice
Recommendation Europe United Kingdom COVID-19
Download:
2024 ∙ ATAGI
ATAGI statement on the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia
Recommendation Western Pacific Australia Influenza
Download:
2024 ∙ NACI
Addendum to the NACI statement on seasonal influenza vaccine for 2024-2025: Transition from quadrivalent to trivalent influenza vaccines
Recommendation Americas Canada Influenza
Download:
2024 ∙ NACI
NACI Statement on seasonal influenza vaccine for 2024–2025
Recommendation Americas Canada Influenza
Download:
2024 ∙ NIAC
recommendations for the passive immunisation of infants against Respiratory Synctytal Virus (RSV) during the 2024/2025 season
Recommendation Europe Ireland RSV (Respiratory syncytial virus)
Download:
2024 ∙ Conseil Supérieur de la Santé (CSS)
Vaccination against seasonal influenza in Belgium - Winter season 2024-2025
Recommendation Europe Belgium Influenza
Download:
2023 ∙ CAVEI
CAVEI recommendation on updating the vaccination strategy against COVID-19 by 2024
Recommendation Americas Chile COVID-19
Download:
2023 ∙ Andrea Silenzi, Andrea Siddu, Anna Carole D'Amelio, Sarah Cataldi, Camilla Fasano, Francesco Maraglino, Giovanni Rezza, Carlo Signorelli
The new Italian National Immunization Technical Advisory Group (NITAG) and its commitment to endorse a new efficient National Immunization Plan in COVID-19 times
Functioning Europe Italy
Download:
Loading...